Prostigmin Drug Interactions
Currently displaying a list of 134 drugs known to interact with Prostigmin (neostigmine).
- 8 major drug interactions
- 125 moderate drug interactions
- 1 minor drug interaction
Medications known to interact with Prostigmin
Note: Showing generic names only.
- belladonna
- benzgalantamine
- benztropine
- betamethasone
- betaxolol
- betaxolol ophthalmic
- bethanechol
- biperiden
- bismuth subsalicylate
- bisoprolol
- brigatinib
- bromfenac
- budesonide
- bupropion
- carteolol
- carteolol ophthalmic
- carvedilol
- clidinium
- clozapine
- corticorelin
- corticotropin
- cortisone
- cosyntropin
- crizotinib
- meclofenamate
- mefenamic acid
- meloxicam
- mepenzolate
- methacholine
- methscopolamine
- methylprednisolone
- metipranolol ophthalmic
- metoprolol
- metrizamide
- paromomycin
- penbutolol
- phenylbutazone
- physostigmine
- pilocarpine
- pindolol
- piroxicam
- plazomicin
- polyethylene glycol 3350 with electrolytes
- ponesimod
- prednisolone
- prednisone
- procainamide
- procyclidine
- propantheline
- propranolol
- pyridostigmine
- tacrine
- thalidomide
- timolol
- timolol ophthalmic
- tobramycin
- tolmetin
- tolterodine
- tramadol
- triamcinolone
- triamcinolone ophthalmic
- trihexyphenidyl
- trospium
Prostigmin disease interactions
There are 6 disease interactions with Prostigmin (neostigmine) which include:
- bradycardia
- coronary artery disease
- parkinsonism
- intestinal/urinary obstruction
- hyperthyroidism
- hepatic impairment
More about Prostigmin (neostigmine)
- Prostigmin consumer information
- Check interactions
- Compare alternatives
- Latest FDA alerts (1)
- Side effects
- Dosage information
- During pregnancy
- Drug class: cholinergic muscle stimulants
- Breastfeeding
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
See also:
Zilbrysq
Zilbrysq (zilucoplan) is a C5 inhibitor used to treat generalized myasthenia gravis (gMG) in AChR ...
Rystiggo
Rystiggo is used to treat generalized myasthenia gravis (gMG) in adults who are acetylcholine ...
Ultomiris
Ultomiris (ravulizumab-cwvz) is used for the treatment of myasthenia gravis, paroxysmal nocturnal ...
Mestinon
Mestinon (pyridostigmine) is used to increase muscle strength in conditions such as myasthenia ...
Vyvgart
Vyvgart is used for myasthenia gravis to improve muscle weakness in adults whose myasthenia gravis ...
Soliris
Soliris infusion is used to treat paroxysmal nocturnal hemoglobinuria (PNH) or neuromyelitis optica ...
Vyvgart Hytrulo
Vyvgart Hytrulo is used to treat generalized myasthenia gravis (gMG) or chronic inflammatory ...
Eculizumab
Eculizumab (brand names Soliris, Bkemv, and Epysqli) is used to treat paroxysmal nocturnal ...
Pyridostigmine
Pyridostigmine is used for dysautonomia, myasthenia gravis, nerve agent pretreatment, reversal of ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.